Page last updated: 2024-10-29

iopromide and Carcinoma, Hepatocellular

iopromide has been researched along with Carcinoma, Hepatocellular in 41 studies

iopromide: structure given in first source
iopromide : A dicarboxylic acid diamide that consists of N-methylisophthalamide bearing three iodo substituents at positions 2, 4 and 6, a methoxyacetyl substituent at position 5 and two 2,3-dihydroxypropyl groups attached to the amide nitrogens. A water soluble x-ray contrast agent for intravascular administration.

Carcinoma, Hepatocellular: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.

Research Excerpts

ExcerptRelevanceReference
"To define the percentage of small (≤2 cm) hepatocellular carcinoma (HCC) nodules showing the diagnostic enhancement pattern at CEUS, computed tomography (CT), and gadobenate dimeglumine (Gd-BOPTA)-enhanced magnetic resonance (MR) imaging."3.79Evidence of diagnostic enhancement pattern in hepatocellular carcinoma nodules ≤2 cm according to the AASLD/EASL revised criteria. ( Angileri, R; Cabibbo, B; Cova, MA; De Paoli, L; Pizzolato, R; Quaia, E, 2013)
"9 months) in 52 patients with hepatocellular carcinoma (HCC): An emulsion of Lipiodol and epirubicin was injected as selectively as possible in a dosage proportional to liver function and tumour size."3.69[The chemoembolization of hepatocellular carcinoma: the computed tomographic findings and clinical results in prospective repetitive therapy]. ( Brambs, HJ; Claussen, CD; Dette, S; Dietz, K; Duda, SH; Geissler, F; Huppert, PE; Lauchart, W, 1994)
"In contrast, among patients with hepatocellular carcinoma, mean contrast enhancement in lesions in the arterial phase was significantly superior in group A compared with group B."2.69Detection of focal liver lesions at biphasic spiral CT: randomized double-blind study of the effect of iodine concentration in contrast materials. ( Balzer, J; Clauss, W; Felfe, R; Felix, R; Hänninen, EL; Pegios, W; Vogl, TJ, 2000)
"Accurate assessment of viability of hepatocellular carcinoma (HCC) after transcatheter arterial chemoembolization (TACE) is important for therapy planning."1.40Parametric response mapping of dynamic CT as an imaging biomarker to distinguish viability of hepatocellular carcinoma treated with transcatheter arterial chemoembolization. ( Choi, SJ; Kim, HS; Kim, J; Lee, JM; Park, H; Seo, J, 2014)
"Although hepatocellular carcinoma (HCC) demonstrates characteristic hypervascularity, some HCCs have a hypovascular pattern on computed tomography (CT)."1.38Prognostic implications of tumor vascularity and its relationship to cytokeratin 19 expression in patients with hepatocellular carcinoma. ( Chung, GE; Jang, JJ; Kim, SH; Kim, YJ; Lee, HS; Lee, JH; Lee, JM; Lee, K; Myung, SJ; Suh, KS; Yoon, JH, 2012)
"Most patients with HCC have coexisting liver cirrhosis (LC) at the time of diagnosis."1.37Incidence and risk factors for radiocontrast-induced nephropathy in patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization. ( Bae, EJ; Chang, SH; Cho, HS; Kang, Y; Kim, HJ; Park, DJ; Seo, JW, 2011)
"In 20 patients with hepatocellular carcinomas, multiphasic liver CT scans including arterial, portal, and equilibrium phases were performed."1.36Image fusion in dual energy computed tomography for detection of hypervascular liver hepatocellular carcinoma: phantom and preliminary studies. ( Cho, SH; Choi, BI; Han, JK; Kim, KS; Kim, KW; Kim, SH; Kim, SJ; Lee, JM, 2010)
"Fifteen patients with either hepatocellular carcinoma (HCC, n = 8) or hypervascular liver metastases from uveal melanoma (n = 7) underwent arterial and portal venous C-arm CT of the liver using intraarterial contrast media administration directly before TACE."1.35Visualization of hypervascular liver lesions During TACE: comparison of angiographic C-arm CT and MDCT. ( Borchert, M; Frericks, BB; Justiz, J; Martus, P; Meyer, BC; Voges, M; Wacker, FK; Wolf, KJ, 2008)

Research

Studies (41)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (9.76)18.2507
2000's9 (21.95)29.6817
2010's27 (65.85)24.3611
2020's1 (2.44)2.80

Authors

AuthorsStudies
Hu, HT1
Shan, QY1
Chen, SL1
Li, B1
Feng, ST1
Xu, EJ1
Li, X1
Long, JY1
Xie, XY1
Lu, MD1
Kuang, M1
Shen, JX1
Wang, W1
Jia, GS1
Feng, GL1
Li, JP1
Xu, HL1
Wang, H2
Cheng, YP1
Yan, LL1
Jiang, HJ1
Lin, EY1
Lee, RC1
Guo, WY1
Wu, FC1
Gehrisch, S1
Kowarschik, M1
Zhang, L1
Wang, N1
Mao, J1
Liu, X1
Gao, Z1
Dai, X1
Feng, B1
Woo, S2
Lee, JM5
Yoon, JH4
Joo, I1
Kim, SH4
Lee, JY1
Kim, YJ3
Han, JK3
Choi, BI3
Chung, JW3
Hur, S2
Joo, SM1
Kim, HC2
Jae, HJ2
Park, JH2
Yu, MH1
Baek, JH1
Flohr, TG1
Quaia, E1
De Paoli, L1
Angileri, R1
Pizzolato, R1
Cabibbo, B1
Cova, MA1
Kim, KA1
Kim, MJ3
Choi, JY1
Park, MS2
Lim, JS1
Chung, YE1
Kim, KW2
Choi, SJ1
Kim, J1
Seo, J1
Kim, HS1
Park, H1
Tan, B1
Zhao, B1
Gong, G1
Xu, Z1
Hoffmann, R1
Rempp, H1
Syha, R1
Ketelsen, D1
Pereira, PL2
Claussen, CD3
Clasen, S1
Kaufmann, S2
Schulze, M2
Spira, D1
Horger, M2
Horger, T1
Oelker, A1
Nikolaou, K1
Li, R1
Cai, P1
Ma, KS1
Ding, SY1
Guo, DY1
Yan, XC1
Zhou, Y1
He, L1
Huang, Y1
Chen, S1
Wu, P1
Ye, W1
Liu, Z1
Liang, C1
Choi, JW1
Lee, JH2
Yu, SJ1
Cho, EJ1
Kim, MU1
Lee, M1
Kim, EY1
Choi, D5
Lim, DH1
Lee, WJ2
Yoo, BC1
Paik, SW1
Balci, NC1
Befeler, AS1
Bieneman, BK1
Fattahi, R1
Saglam, S1
Havlioglu, N1
Park, Y1
Kim, YS4
Rhim, H4
Lim, HK4
Choi, JI1
Choi, HJ1
Jung, DC1
Hong, EK1
Park, JW1
Jang, YJ1
Kim, CM1
Kim, KS1
Kim, SJ1
Cho, SH1
Kim, JH1
Yoon, HK1
Ko, GY1
Gwon, DI1
Jang, CS1
Song, HY1
Shin, JH1
Sung, KB1
Kim, JE1
Lee, MW3
Shin, SW1
Cho, SK1
Chung, GE1
Myung, SJ1
Lee, K1
Jang, JJ1
Suh, KS1
Lee, HS1
Cho, HS1
Seo, JW1
Kang, Y1
Bae, EJ1
Kim, HJ1
Chang, SH1
Park, DJ1
Yuan, Z1
Ye, XD1
Dong, S1
Xu, LC1
Xiao, XS1
Cha, DI1
Chung, WS1
Lee, KH1
Lee, YJ1
Kwon, J1
Baek, SE1
Bova, V1
Miraglia, R1
Maruzzelli, L1
Vizzini, GB1
Luca, A1
Lee, HY1
Park, MJ1
Kim, YK1
Choi, YA1
Kim, CK1
Park, BK1
Kim, B1
Lin, J1
Zhou, KR1
Chen, ZW1
Wang, JH1
Yan, ZP1
Wang, YX1
Song, SY1
Lim, HG1
Meyer, BC1
Frericks, BB1
Voges, M1
Borchert, M1
Martus, P1
Justiz, J1
Wolf, KJ1
Wacker, FK1
Huppert, PE1
Geissler, F1
Duda, SH1
Lauchart, W1
Dette, S1
Dietz, K1
Brambs, HJ1
Pacella, CM1
Bizzarri, G1
Anelli, V1
Valle, D1
Fabbrini, R1
Bianchini, A1
Fenderico, P1
Rossi, Z1
Luboldt, W1
Straub, J1
Seemann, M1
Helmberger, T1
Reiser, M1
Kopka, L1
Grabbe, E1
Hänninen, EL1
Vogl, TJ1
Felfe, R1
Pegios, W1
Balzer, J1
Clauss, W1
Felix, R1
Mehnert, F1
Trübenbach, J1
Kopp, AF1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
The Artificial Intelligent Prognostic Assessment and Pathological Basis Research of Early Primary Hepatocellular Carcinoma After Minimally Invasive Treatment Based on Multimodal MRI and Clinical Big Data[NCT04299919]1,200 participants (Anticipated)Observational2007-04-01Active, not recruiting
Recurrence Risk Factors of Early-Stage Hepatocellular Carcinoma After Radio Frequency Ablation: a Multi-center Prospective Case-control Study[NCT02046356]139 participants (Actual)Observational [Patient Registry]2014-01-31Active, not recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for iopromide and Carcinoma, Hepatocellular

ArticleYear
CT findings of primary clear cell carcinoma of liver: with analysis of 19 cases and review of the literature.
    Abdominal imaging, 2014, Volume: 39, Issue:4

    Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Female; Humans; Ioh

2014

Trials

3 trials available for iopromide and Carcinoma, Hepatocellular

ArticleYear
Change in contrast enhancement of HCC on 1-month follow-up CT after local radiotherapy: an early predictor of final treatment response.
    European journal of radiology, 2009, Volume: 72, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Female; Humans; Iohexol;

2009
Detection of focal liver lesions at biphasic spiral CT: randomized double-blind study of the effect of iodine concentration in contrast materials.
    Radiology, 2000, Volume: 216, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Aorta; Carcinoma, Hepatocellular; Contrast Media; Double-Blind Metho

2000
Biphasic spiral CT of the liver: automatic bolus tracking or time delay?
    European radiology, 2001, Volume: 11, Issue:3

    Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Female; Humans; Image Processing, Computer-A

2001

Other Studies

37 other studies available for iopromide and Carcinoma, Hepatocellular

ArticleYear
CT-based radiomics for preoperative prediction of early recurrent hepatocellular carcinoma: technical reproducibility of acquisition and scanners.
    La Radiologia medica, 2020, Volume: 125, Issue:8

    Topics: Adult; Aged; Algorithms; Biomarkers, Tumor; Carcinoma, Hepatocellular; Contrast Media; Female; Hepat

2020
Using receiver operating characteristic curves to evaluate the diagnostic value of the combination of multislice spiral CT and alpha-fetoprotein levels for small hepatocellular carcinoma in cirrhotic patients.
    Hepatobiliary & pancreatic diseases international : HBPD INT, 2017, Volume: 16, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Carcinoma, Hepatocellular; Case-Control Studies; C

2017
Three-Dimensional Quantitative Color-Coding Analysis of Hepatic Arterial Flow Change during Chemoembolization of Hepatocellular Carcinoma.
    Journal of vascular and interventional radiology : JVIR, 2018, Volume: 29, Issue:10

    Topics: Aged; Aged, 80 and over; Angiography; Angiography, Digital Subtraction; Blood Flow Velocity; Carcino

2018
Dual-Energy CT-Derived Volumetric Iodine Concentration for the Assessment of Therapeutic Response after Microwave Ablation in a Rabbit Model with Intrahepatic VX2 Tumor.
    Journal of vascular and interventional radiology : JVIR, 2018, Volume: 29, Issue:10

    Topics: Ablation Techniques; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Contrast Media; Iohexol;

2018
Small- and medium-sized hepatocellular carcinomas: monopolar radiofrequency ablation with a multiple-electrode switching system-mid-term results.
    Radiology, 2013, Volume: 268, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Catheter Ablation; Contrast Media; Female

2013
Liver abscess after transarterial chemoembolization in patients with bilioenteric anastomosis: frequency and risk factors.
    AJR. American journal of roentgenology, 2013, Volume: 200, Issue:6

    Topics: Adult; Aged; Anastomosis, Surgical; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Contr

2013
Low tube voltage intermediate tube current liver MDCT: sinogram-affirmed iterative reconstruction algorithm for detection of hypervascular hepatocellular carcinoma.
    AJR. American journal of roentgenology, 2013, Volume: 201, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Algorithms; Analysis of Variance; Carcinoma, Hepatocellular; Contras

2013
Evidence of diagnostic enhancement pattern in hepatocellular carcinoma nodules ≤2 cm according to the AASLD/EASL revised criteria.
    Abdominal imaging, 2013, Volume: 38, Issue:6

    Topics: Aged; Biopsy; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Female; Humans; Im

2013
Detection of recurrent hepatocellular carcinoma on post-operative surveillance: comparison of MDCT and gadoxetic acid-enhanced MRI.
    Abdominal imaging, 2014, Volume: 39, Issue:2

    Topics: Aged; Carcinoma, Hepatocellular; Contrast Media; Female; Gadolinium DTPA; Humans; Iohexol; Liver Neo

2014
Parametric response mapping of dynamic CT as an imaging biomarker to distinguish viability of hepatocellular carcinoma treated with transcatheter arterial chemoembolization.
    Abdominal imaging, 2014, Volume: 39, Issue:3

    Topics: Aged; Area Under Curve; Biomarkers, Tumor; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic

2014
Transarterial chemoembolization using drug eluting beads and subsequent percutaneous MR-guided radiofrequency ablation in the therapy of intermediate sized hepatocellular carcinoma.
    European journal of radiology, 2014, Volume: 83, Issue:10

    Topics: Aged; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Catheter Ablation; Chemoembolization,

2014
Comparison of volume perfusion computed tomography and contrast-enhanced ultrasound for assessment of therapeutic effect of transarterial chemoembolization in patients with hepatocellular carcinoma: a preliminary report.
    Acta radiologica (Stockholm, Sweden : 1987), 2016, Volume: 57, Issue:1

    Topics: Aged; Aged, 80 and over; Blood Volume; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Co

2016
Reproducibility of VPCT parameters in the normal pancreas: comparison of two different kinetic calculation models.
    Academic radiology, 2015, Volume: 22, Issue:9

    Topics: Adult; Aged; Blood Volume; Carcinoma, Hepatocellular; Cone-Beam Computed Tomography; Contrast Media;

2015
Dynamic enhancement patterns of intrahepatic cholangiocarcinoma in cirrhosis on contrast-enhanced computed tomography: risk of misdiagnosis as hepatocellular carcinoma.
    Scientific reports, 2016, 05-26, Volume: 6

    Topics: Adult; Aged; Biomarkers, Tumor; Carcinoma, Hepatocellular; Cholangiocarcinoma; Contrast Media; Diagn

2016
CT-based radiomics signature: a potential biomarker for preoperative prediction of early recurrence in hepatocellular carcinoma.
    Abdominal radiology (New York), 2017, Volume: 42, Issue:6

    Topics: Adult; Aged; Biomarkers, Tumor; Carcinoma, Hepatocellular; Contrast Media; Female; Hepatectomy; Huma

2017
Cone Beam CT-Guided Chemoembolization of Probable Hepatocellular Carcinomas Smaller than 1 cm in Patients at High Risk of Hepatocellular Carcinoma.
    Journal of vascular and interventional radiology : JVIR, 2017, Volume: 28, Issue:6

    Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cone-Beam Computed Tomography; Contrast M

2017
Fat containing HCC: findings on CT and MRI including serial contrast-enhanced imaging.
    Academic radiology, 2009, Volume: 16, Issue:8

    Topics: Adipose Tissue; Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Female; Gadolinium DTPA; Hum

2009
Arterial enhancement of hepatocellular carcinoma before radiofrequency ablation as a predictor of postablation local tumor progression.
    AJR. American journal of roentgenology, 2009, Volume: 193, Issue:3

    Topics: Aged; Arteries; Carcinoma, Hepatocellular; Catheter Ablation; Contrast Media; Disease Progression; F

2009
Diagnostic value of early-phase-enhanced computed tomography for the differentiation of pulmonary metastases from hepatocellular carcinoma and primary lung cancer.
    Acta radiologica (Stockholm, Sweden : 1987), 2009, Volume: 50, Issue:9

    Topics: Adolescent; Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Female;

2009
Image fusion in dual energy computed tomography for detection of hypervascular liver hepatocellular carcinoma: phantom and preliminary studies.
    Investigative radiology, 2010, Volume: 45, Issue:3

    Topics: Adult; Aged; Analysis of Variance; Carcinoma, Hepatocellular; Contrast Media; Female; Humans; Iohexo

2010
Nonresectable combined hepatocellular carcinoma and cholangiocarcinoma: analysis of the response and prognostic factors after transcatheter arterial chemoembolization.
    Radiology, 2010, Volume: 255, Issue:1

    Topics: Adult; Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cholangiocarcinoma; Cisplati

2010
Outcomes of patients with hepatocellular carcinoma referred for percutaneous radiofrequency ablation at a tertiary center: analysis focused on the feasibility with the use of ultrasonography guidance.
    European journal of radiology, 2011, Volume: 79, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Biopsy, Needle; Carcinoma, Hepatocellular; Catheter Ablation; Contra

2011
Prognostic implications of tumor vascularity and its relationship to cytokeratin 19 expression in patients with hepatocellular carcinoma.
    Abdominal imaging, 2012, Volume: 37, Issue:3

    Topics: Biomarkers, Tumor; Carcinoma, Hepatocellular; Chi-Square Distribution; Contrast Media; Female; Human

2012
Incidence and risk factors for radiocontrast-induced nephropathy in patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization.
    Clinical and experimental nephrology, 2011, Volume: 15, Issue:5

    Topics: Acute Kidney Injury; Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Contrast Media

2011
Evaluation of early imaging response after chemoembolization of hepatocellular carcinoma by phosphorus-31 magnetic resonance spectroscopy-initial experience.
    Journal of vascular and interventional radiology : JVIR, 2011, Volume: 22, Issue:8

    Topics: Adult; Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Contrast Media; Ethiodized O

2011
Percutaneous radiofrequency ablation of hepatocellular carcinoma: fusion imaging guidance for management of lesions with poor conspicuity at conventional sonography.
    AJR. American journal of roentgenology, 2012, Volume: 198, Issue:6

    Topics: Carcinoma, Hepatocellular; Catheter Ablation; Contrast Media; Female; Humans; Image Enhancement; Ima

2012
Enhancement patterns of hepatocellular carcinoma after transarterial chemoembolization using drug-eluting beads on arterial phase CT images: a pilot retrospective study.
    AJR. American journal of roentgenology, 2012, Volume: 199, Issue:2

    Topics: Adult; Aged; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic;

2012
Predictive factors of downstaging of hepatocellular carcinoma beyond the Milan criteria treated with intra-arterial therapies.
    Cardiovascular and interventional radiology, 2013, Volume: 36, Issue:2

    Topics: Adult; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Chi-Square Distribution; Contrast

2013
Early diffuse recurrence of hepatocellular carcinoma after percutaneous radiofrequency ablation: analysis of risk factors.
    European radiology, 2013, Volume: 23, Issue:1

    Topics: Aged; Biopsy; Carcinoma, Hepatocellular; Case-Control Studies; Catheter Ablation; Contrast Media; Di

2013
Evaluation of adrenal metastases from renal cell carcinoma and hepatocellular carcinoma: use of delayed contrast-enhanced CT.
    Radiology, 2013, Volume: 266, Issue:2

    Topics: Adrenal Gland Neoplasms; Adult; Aged; Carcinoma, Hepatocellular; Carcinoma, Renal Cell; Contrast Med

2013
3D contrast-enhanced MR portography and direct X-ray portography: a correlation study.
    European radiology, 2003, Volume: 13, Issue:6

    Topics: Adult; Carcinoma, Hepatocellular; Contrast Media; Female; Gadolinium DTPA; Humans; Hypertension, Por

2003
Nonhepatic arteries originating from the hepatic arteries: angiographic analysis in 250 patients.
    Journal of vascular and interventional radiology : JVIR, 2006, Volume: 17, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Angiography; Angiography, Digital Subtraction; Carcinoma, Hepatocell

2006
Visualization of hypervascular liver lesions During TACE: comparison of angiographic C-arm CT and MDCT.
    AJR. American journal of roentgenology, 2008, Volume: 190, Issue:4

    Topics: Adult; Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Contrast Media; Diagnosis, D

2008
[The chemoembolization of hepatocellular carcinoma: the computed tomographic findings and clinical results in prospective repetitive therapy].
    RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 1994, Volume: 160, Issue:5

    Topics: Adult; Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Clinical Protocols; Contrast

1994
Evaluation of the vascular pattern of hepatocellular carcinoma with dynamic computed tomography and its use in identifying optimal temporal windows for helical computed tomography.
    European radiology, 1998, Volume: 8, Issue:1

    Topics: Aged; Aorta, Abdominal; Carcinoma, Hepatocellular; Contrast Media; Evaluation Studies as Topic; Fema

1998
Effective contrast use in CT angiography and dual-phase hepatic CT performed with a subsecond scanner.
    Investigative radiology, 1999, Volume: 34, Issue:12

    Topics: Angiography; Carcinoma, Hepatocellular; Contrast Media; Female; Hemangioma; Humans; Injections, Intr

1999
[Biphasic liver diagnosis with multiplanar-detector spiral CT].
    Der Radiologe, 1999, Volume: 39, Issue:11

    Topics: Adult; Carcinoma, Hepatocellular; Contrast Media; Female; Humans; Iohexol; Liver; Liver Neoplasms; M

1999